J B Chemicals & Pharmaceuticals jumped 11.7% to Rs 348.45 at 14:10 IST on BSE after net profit rose 25.79% to Rs 49.85 crore on 7.75% rise in net sales to Rs 300.79 crore in Q1 June 2016 over Q1 June 2015.
The result was announced during market hours today, 26 August 2016.Meanwhile, the S&P BSE Sensex was down 109.81 points, or 0.39%, to 27,726.10
On BSE, so far 5.61 lakh shares were traded in the counter as against average daily volume of 22,244 shares in the past one quarter. The stock hit a high of Rs 353.75 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 311 so far during the day. The stock had hit a 52-week low of Rs 228.30 on 12 February 2016. The stock had outperformed the market over the past 30 days till 25 August 2016, rising 14.14% compared with Sensex's 0.67% fall. The scrip had also outperformed the market in past one quarter, advancing 22.02% as against Sensex's 4.44% rise.
The small-cap company has an equity capital of Rs 16.96 crore. Face value per share is Rs 2.
J B Chemicals & Pharmaceuticals, one of India's leading pharmaceutical companies, manufactures & markets a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (API)'s.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
